Submission for OMB Review; 30-Day Comment Request Scientific Information Reporting System (SIRS) NIGMS, 70829-70830 [2015-29085]

Download as PDF 70829 Federal Register / Vol. 80, No. 220 / Monday, November 16, 2015 / Notices property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Minority Health and Health Disparities Special Emphasis Panel, TCC Precision Medicine Face-to-Face Review Meeting. Date: December 8–December 9, 2015. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Conference Center, Marriott at Marinelli Road, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Maryline Laude-Sharp, Ph.D., Scientific Review Officer, National Institute on Minority Health and Health Disparities, National Institutes of Health, 6707 Democracy Blvd., Suite 800, Bethesda, MD 20892, (301) 451–9536, mlaudesharp@ nih.gov. Dated: November 9, 2015. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015–28833 Filed 11–13–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Submission for OMB Review; 30-Day Comment Request Scientific Information Reporting System (SIRS) NIGMS Under the provisions of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information collection was previously published in the Federal Register on August 23, 2015, page 48549 and allowed 60-days for public comment. One public SUMMARY: obtain supplemental information to the annual Research Performance Progress Report (RPPR) submitted by grantees of the Institutional Development Award (IDeA) Program and the Native American Research Center for Health (NARCH) Program. The SIRS will collect program-specific data not requested in the RPPR data collection system. The IDeA Program is a congressionally mandated, long-term interventional program administered by NIGMS aimed at developing and/or enhancing the biomedical research competitiveness of States and Jurisdictions that lag in NIH funding. The NARCH Program is an interagency initiative that provides support to American Indian and Alaska Native (AI/ AN) tribes and organizations for conducting research in their communities in order to address health disparities, and to develop a cadre of competitive AI/AN scientists and health professionals. The data collected by SIRS will provide valuable information for the following purposes: (1) Evaluation of progress by individual grantees towards achieving granteedesignated and program-specified goals and objectives, (2) evaluation of the overall program for effectiveness, efficiency, and impact in building biomedical research capacity and capability, and (3) analysis of outcome measures to determine need for refinements and/or adjustments of different program features including but not limited to initiatives and eligibility criteria. Data collected from SIRS will be used for various regular or ad hoc reporting requests from interested stakeholders that include members of Congress, state and local officials, other federal agencies, professional societies, media, and other parties. OMB approval is requested for 3 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 613. comment was received. The purpose of this notice is to allow an additional 30 days for public comment. The National Institute of General Medical Sciences (NIGMS), National Institutes of Health, may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. Direct Comments To OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, OIRA_submission@ omb.eop.gov or by fax to 202–395–6974, Attention: NIH Desk Officer. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication. FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data collection plans and instruments or request more information on the proposed project contact: Dr. W. Fred Taylor Ph.D., Branch Chief, Capacity-Building Branch (CBB), Division of Training, Workforce Development, and Diversity (TWD), NIGMS, NIH, 45 Center Drive, Room 2AS43S, Bethesda MD 20892, or call non-toll-free number (301) 435–0760 or Email your request, including your address to: taylorwf@mail.nih.gov. Formal requests for additional plans and instruments must be requested in writing. Proposed Collection: Scientific Information Reporting System (SIRS), 0925-In Use Without OMB Control Number, National Institute of General Medical Sciences (NIGMS), National Institutes of Health (NIH). Need and Use of Information Collection: The SIRS is an online data collection system whose purpose is to ESTIMATED ANNUALIZED BURDEN HOURS tkelley on DSK3SPTVN1PROD with NOTICES Form name SIRS SIRS SIRS SIRS SIRS SIRS ................. ................. ................. ................. ................. ................. VerDate Sep<11>2014 Number of respondents Respondents Principal Principal Principal Principal Principal Principal Investigators, Investigators, Investigators, Investigators, Investigators, Investigators, 19:47 Nov 13, 2015 Jkt 238001 COBRE Phase I .......................... COBRE Phase II ......................... COBRE Phase III ........................ INBRE ......................................... IDeA–CTR ................................... NARCH ....................................... PO 00000 Frm 00083 Fmt 4703 Sfmt 4703 Number of responses per respondent 37 36 35 24 5 19 E:\FR\FM\16NON1.SGM 1 1 1 1 1 1 16NON1 Average burden hours per response 3.5 3.5 3.5 5.5 3.5 4.5 Total annual burden hours 130 126 122 132 18 85 70830 Federal Register / Vol. 80, No. 220 / Monday, November 16, 2015 / Notices Dated: November 10, 2015. Tammy Dean-Maxwell, Project Clearance Branch Liaison, NIGMS, NIH. [FR Doc. 2015–29085 Filed 11–13–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Notice of Opportunity for Public Comment on the Dietary Supplement Label Database This document, originally published on October 29, 2015 (80 FR 66549), has been amended to extend the comment receipt date to December 31, 2015. The Office of Dietary Supplements (ODS) at the National Institutes of Health, in partnership with the National Library of Medicine (NLM), has developed a Dietary Supplement Label Database (DSLD) that is compiling all information from the labels of dietary supplements marketed in the United States. ODS welcomes comments about features to add and functionality improvements to make so the DSLD may become a more useful tool to users. A federal stakeholder panel for the DSLD will consider all comments received. The ODS requests input from academic researchers, government agencies, the dietary supplement industry, and other interested parties, including consumers. The DSLD can be accessed online at https:// dsld.nlm.nih.gov. SUMMARY: To ensure full consideration, all comments must be received by 11:59 p.m. EST, December 31, 2015. ADDRESSES: Interested individuals and organizations should submit their responses to ODS@nih.gov. FOR FURTHER INFORMATION CONTACT: Richard Bailen MBA, MHA, Office of Dietary Supplements, National Institutes of Health, 6100 Executive Boulevard, Room 3B01, Bethesda, MD 20892–7517, Phone: 301–435–2920, Fax: 301–480–1845, Email: ODS@ nih.gov. DATES: The DSLD is a free resource that captures all information present on dietary supplement labels as provided by the seller, including contents, ingredient amounts, and any health-related product statements, claims, and cautions. It also provides a downloadable photo of each label. Users can search for and organize this information in various ways. Research scientists, for example, could use the tkelley on DSK3SPTVN1PROD with NOTICES SUPPLEMENTARY INFORMATION: VerDate Sep<11>2014 19:47 Nov 13, 2015 Jkt 238001 DSLD to determine total nutrient intakes from food and supplements in populations they study. Health care providers can learn the content of products their patients are taking. Consumers might use the DSLD to search for and compare products of interest. The DSLD currently contains 50,000 labels, and it is expected to grow rapidly over the next three years to include most of the estimated 75,000+ dietary supplement products sold to American consumers. The DSLD is updated regularly to include any formulation changes and label information in a product. It also includes the labels of products that have been discontinued and are no longer sold. More information about the DSLD and its current capabilities is available at https:// www.dsld.nlm.nih.gov and at Dwyer et al., 2014.1 ODS would like to receive ideas and suggestions for how the DSLD might evolve. What features might be added, improved, or enhanced—for example, in capabilities related to search, sorting, organization, and downloading of information—that would make it a more valuable tool for users? Dated: November 5, 2015. Lawrence A. Tabak, Deputy Director, National Institutes of Health. [FR Doc. 2015–29177 Filed 11–13–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. 1 Dwyer JT, Saldanha LG, Bailen RA, et al. A free new dietary supplement label database for registered dietitian nutritionists. J Acad Nutr Diet. 2014;114(10):1512–7. PO 00000 Frm 00084 Fmt 4703 Sfmt 4703 Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, NIAID Clinical Trial Planning Grant (R34) and Implementation Cooperative Agreement (U01). Date: December 9, 2015. Time: 1:30 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Room 3C100, 5601 Fishers Lane, Rockville, MD 20892, (Telephone Conference Call). Contact Person: Frank S. De Silva, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, Room #3E72A, National Institutes of Health/ NIAID, 5601 Fishers Lane, MSC 9823, Bethesda, MD 20892–9823, (240) 669–5023, fdesilva@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: November 9, 2015. Natasha Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015–28835 Filed 11–13–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Prospective Grant of Exclusive License: Development of Cripto-1 Point of Care (POC) Tests and Kits for the Detection of Cancer National Institutes of Health, Public Health Service, HHS. ACTION: Notice. AGENCY: This notice, in accordance with 35 U.S.C. 209 and 37 CFR part 404, that the National Cancer Institute, National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to practice the inventions embodied in the following U.S. Patents and Patent Applications to Beacon Biomedical, Inc. (‘‘Beacon’’) located in Scottsdale, AZ, USA. A notice was previously published on December 6, 2013 in Volume 78, Number 235 for a period of thirty (30) days. Herein, the National Cancer Institute, National Institutes of Health, Department of Health and Human Services, is proposing a modification to the contents of the previous notice regarding the following intellectual property: SUMMARY: U.S. Provisional Patent Application No. 60/ 264,643 filed January 26, 2001 entitled ‘‘Detection and Quantification of Cripto1’’ [HHS Ref. No. E–290–2000/0–US–01]; E:\FR\FM\16NON1.SGM 16NON1

Agencies

[Federal Register Volume 80, Number 220 (Monday, November 16, 2015)]
[Notices]
[Pages 70829-70830]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-29085]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Submission for OMB Review; 30-Day Comment Request Scientific 
Information Reporting System (SIRS) NIGMS

SUMMARY: Under the provisions of Section 3507(a)(1)(D) of the Paperwork 
Reduction Act of 1995, the National Institutes of Health (NIH) has 
submitted to the Office of Management and Budget (OMB) a request for 
review and approval of the information collection listed below. This 
proposed information collection was previously published in the Federal 
Register on August 23, 2015, page 48549 and allowed 60-days for public 
comment. One public comment was received. The purpose of this notice is 
to allow an additional 30 days for public comment. The National 
Institute of General Medical Sciences (NIGMS), National Institutes of 
Health, may not conduct or sponsor, and the respondent is not required 
to respond to, an information collection that has been extended, 
revised, or implemented on or after October 1, 1995, unless it displays 
a currently valid OMB control number.
    Direct Comments To OMB: Written comments and/or suggestions 
regarding the item(s) contained in this notice, especially regarding 
the estimated public burden and associated response time, should be 
directed to the: Office of Management and Budget, Office of Regulatory 
Affairs, OIRA_submission@omb.eop.gov or by fax to 202-395-6974, 
Attention: NIH Desk Officer.
    Comment Due Date: Comments regarding this information collection 
are best assured of having their full effect if received within 30-days 
of the date of this publication.

FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data 
collection plans and instruments or request more information on the 
proposed project contact: Dr. W. Fred Taylor Ph.D., Branch Chief, 
Capacity-Building Branch (CBB), Division of Training, Workforce 
Development, and Diversity (TWD), NIGMS, NIH, 45 Center Drive, Room 
2AS43S, Bethesda MD 20892, or call non-toll-free number (301) 435-0760 
or Email your request, including your address to: 
taylorwf@mail.nih.gov. Formal requests for additional plans and 
instruments must be requested in writing.
    Proposed Collection: Scientific Information Reporting System 
(SIRS), 0925-In Use Without OMB Control Number, National Institute of 
General Medical Sciences (NIGMS), National Institutes of Health (NIH).
    Need and Use of Information Collection: The SIRS is an online data 
collection system whose purpose is to obtain supplemental information 
to the annual Research Performance Progress Report (RPPR) submitted by 
grantees of the Institutional Development Award (IDeA) Program and the 
Native American Research Center for Health (NARCH) Program. The SIRS 
will collect program-specific data not requested in the RPPR data 
collection system. The IDeA Program is a congressionally mandated, 
long-term interventional program administered by NIGMS aimed at 
developing and/or enhancing the biomedical research competitiveness of 
States and Jurisdictions that lag in NIH funding. The NARCH Program is 
an interagency initiative that provides support to American Indian and 
Alaska Native (AI/AN) tribes and organizations for conducting research 
in their communities in order to address health disparities, and to 
develop a cadre of competitive AI/AN scientists and health 
professionals. The data collected by SIRS will provide valuable 
information for the following purposes: (1) Evaluation of progress by 
individual grantees towards achieving grantee-designated and program-
specified goals and objectives, (2) evaluation of the overall program 
for effectiveness, efficiency, and impact in building biomedical 
research capacity and capability, and (3) analysis of outcome measures 
to determine need for refinements and/or adjustments of different 
program features including but not limited to initiatives and 
eligibility criteria. Data collected from SIRS will be used for various 
regular or ad hoc reporting requests from interested stakeholders that 
include members of Congress, state and local officials, other federal 
agencies, professional societies, media, and other parties.
    OMB approval is requested for 3 years. There are no costs to 
respondents other than their time. The total estimated annualized 
burden hours are 613.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
         Form name               Respondents         Number of     responses per     hours per     Total annual
                                                    respondents     respondent       response      burden hours
----------------------------------------------------------------------------------------------------------------
SIRS......................  Principal                         37               1             3.5             130
                             Investigators,
                             COBRE Phase I.
SIRS......................  Principal                         36               1             3.5             126
                             Investigators,
                             COBRE Phase II.
SIRS......................  Principal                         35               1             3.5             122
                             Investigators,
                             COBRE Phase III.
SIRS......................  Principal                         24               1             5.5             132
                             Investigators,
                             INBRE.
SIRS......................  Principal                          5               1             3.5              18
                             Investigators, IDeA-
                             CTR.
SIRS......................  Principal                         19               1             4.5              85
                             Investigators,
                             NARCH.
----------------------------------------------------------------------------------------------------------------



[[Page 70830]]

    Dated: November 10, 2015.
Tammy Dean-Maxwell,
Project Clearance Branch Liaison, NIGMS, NIH.
[FR Doc. 2015-29085 Filed 11-13-15; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.